bromodeoxyuridine has been researched along with Carcinoma, Non-Small Cell Lung in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, J; Kang, S; Kim, JH; Ko, SG; Kwon, YY; Moon, JH | 1 |
| Chen, X; Fu, G; Ge, M; Wang, M | 1 |
| Çetin, İ; Topçul, M | 1 |
| Fang, K; Hsieh, CH; Ni, YL; Wang, JP | 1 |
| Carrillo Garcia, C; Glassmann, A; Janzen, V; Kraus, D; Probstmeier, R; Veit, N; Winter, J | 1 |
| Harris, CC; Pine, SR; Robles, AI; Ryan, BM; Varticovski, L | 1 |
| Civelek, AC; Huang, T; Jiang, H; Li, J; Li, XF; Ng, CK; Postel, GC; Shen, B | 1 |
| Kataki, A; Marie, B; Martinet, N; Martinet, Y; Piet, M; Scheid, P; Vignaud, JM | 1 |
| Angulo, JF; Biard, DS; Créminon, C; Despras, E; Harper, F; Miccoli, L; Pichard, E | 1 |
| Au, JL; Lu, Z; Wientjes, TS | 1 |
| Biesaga, B; Gasińska, A; Kolodziejski, L | 1 |
| Henfling, ME; Meijer, L; Nieland, L; Ramaekers, FC; Schutte, B; van Engeland, M | 1 |
| Angulo, JF; Kannouche, P | 1 |
| Goehde, W; Hemmer, J; Mauro, F; Salvati, F; Storniello, G; Teodori, L; Trinca, ML | 1 |
14 other study(ies) available for bromodeoxyuridine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
SH005S7 Overcomes Primary and Acquired Resistance of Non-Small Cell Lung Cancer by Combined MET/EGFR/HER3 Inhibition.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Ki-67 Antigen; Lung Neoplasms; Matrix Metalloproteinase 9; Mice; Mice, Nude; Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Quinazolines; Tumor Necrosis Factor-alpha; Vimentin | 2022 |
Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS‑mutated lung cancer cells.
Topics: Agar; Bromodeoxyuridine; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Glutathione Peroxidase; Humans; Lung; Lung Neoplasms; Matrix Metalloproteinase 1; MicroRNAs; Proto-Oncogene Proteins p21(ras); Reactive Oxygen Species | 2022 |
Antiproliferative Effects of EGFR inhibitor Cetuximab and PARP Inhibitor Combination on Non-Small Cell Lung Cancer Cell Line A549 and Cervical Cancer Cell Line HeLa.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cetuximab; ErbB Receptors; Female; HeLa Cells; Humans; Lung Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Uterine Cervical Neoplasms | 2022 |
Teroxirone motivates apoptotic death in tumorspheres of human lung cancer cells.
Topics: Apoptosis; Biomarkers, Tumor; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Fluorescence; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Neoplastic Stem Cells; Spheroids, Cellular; Triazines; Tumor Stem Cell Assay | 2018 |
Staurosporine Induces the Generation of Polyploid Giant Cancer Cells in Non-Small-Cell Lung Carcinoma A549 Cells.
Topics: A549 Cells; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cell Size; Giant Cells; Humans; Lung Neoplasms; Polyploidy; Staurosporine | 2018 |
Microenvironmental modulation of asymmetric cell division in human lung cancer cells.
Topics: AC133 Antigen; Antigens, CD; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Line, Tumor; DNA Replication; DNA, Neoplasm; Glycoproteins; Humans; Lung Neoplasms; Peptides; Tumor Cells, Cultured | 2010 |
Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.
Topics: Animals; Biological Transport; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Misonidazole; Necrosis; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radioactive Tracers; Tumor Microenvironment | 2012 |
Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression.
Topics: Biomarkers, Tumor; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Disease Progression; DNA Replication; Female; Histocompatibility Testing; HLA Antigens; Humans; Immunoenzyme Techniques; In Situ Hybridization; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Macrophages, Alveolar; Male; Middle Aged; Neoplasm Staging | 2002 |
Participation of kin17 protein in replication factories and in other DNA transactions mediated by high molecular weight nuclear complexes.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Division; Colonic Neoplasms; DNA Replication; DNA-Binding Proteins; Flow Cytometry; Humans; Hydroxyurea; Lung Neoplasms; Microscopy, Immunoelectron; Mimosine; Nuclear Proteins; RNA-Binding Proteins; Tumor Cells, Cultured; Zinc Fingers | 2003 |
Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Docetaxel; Drug Synergism; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Paclitaxel; Suramin; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays | 2005 |
Tumour cell kinetics as prognostic factor in surgically-treated-non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Bromodeoxyuridine; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Division; Flow Cytometry; Humans; Lung Neoplasms; Middle Aged; Prognosis; S Phase; Survival Rate | 1997 |
The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.
Topics: Antimetabolites; Apoptosis; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; CDC2 Protein Kinase; Cell Cycle; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; G2 Phase; Humans; Kinetin; Lung Neoplasms; Mitosis; Neuroblastoma; Purines; Roscovitine; S Phase; Tumor Cells, Cultured | 1997 |
Overexpression of kin17 protein disrupts nuclear morphology and inhibits the growth of mammalian cells.
Topics: Animals; Antigens, Polyomavirus Transforming; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Nucleus; Chromatin; DNA Replication; DNA-Binding Proteins; DNA, Complementary; Extrachromosomal Inheritance; Gene Deletion; Gene Expression Regulation, Neoplastic; Genes, Dominant; HeLa Cells; Humans; Lung Neoplasms; Mammals; Mutagenesis; Nuclear Proteins; Nucleic Acid Conformation; Rec A Recombinases; RNA-Binding Proteins; S Phase; Zinc Fingers | 1999 |
Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (BUdR) monoclonal antibody method: comparison with DNA flow cytometric data.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Humans; Interphase; Lung Neoplasms; Neoplasm Proteins; Tumor Cells, Cultured | 1990 |